Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
An antigen recognition receptor is a broad term used to describe the surface molecules expressed on lymphocytes (notably B cells and T cells) that specifically recognize antigens—a critical step in triggering adaptive immune responses. In vertebrates, the major classes of these receptors are the B cell receptor (BCR), found on B lymphocytes, and the T cell receptor (TCR), found on T lymphocytes. Each receptor is unique to a lymphocyte clone and is highly diverse, enabling recognition of a vast array of antigens. This diversity results from genetic recombination events during lymphocyte development (V(D)J recombination). When these receptors bind their respective antigens (directly in the case of BCRs, or via MHC-bound peptide for TCRs), the cell is activated, leading to an immune response such as antibody production or cellular cytotoxicity. As a group, "antigen recognition receptors" do not denote a distinct molecular target but encompass multiple structurally and functionally related proteins critical for immune defense.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antigen recognition receptor.